Physician Profile

Physician Profile

Ashiq Masood, MD

Oncology / Hematology

Education

Medical School
Sher-I-Kashmir Institute of Medical Sciences, Srinagar,
Residency
Internal Medicine, Detroit Med Center/Wayne State University, Detroit, MI
Fellowship
Med/Hematology-Oncol, University of Maryland Program, Baltimore, MD

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine - Subspecialty in Hematology
  • American Board of Internal Medicine - Subspecialty in Medical Oncology

Academic Titles

  • Clinical Assistant Professor, University of Missouri–Kansas City School of Medicine

Clinical Interests

  • gastrointestinal cancers
  • solid tumors
  • cancer genomics and immunotherapy
  • clinical trials

Biography

I am a medical oncologist at Saint Luke's Cancer Institute (SLCI) specializing in gastrointestinal cancers. I am board certified in medical oncology, hematology, and internal medicine.

Previously, I was an Assistant Professor in the Division of Oncology at Washington University School of Medicine in Saint Louis, specializing is gastrointestinal cancers. My current research focus is to develop effective biomarker-driven therapies to our cancer patients. Furthermore, my other focus to study large genomic datasets to discover novel and clinically actionable alterations to help to develop newer effective treatments in our patients.

During my clinical fellowship, I was a post-doctoral fellow in Scott Devine's Lab at the Institute for Genomic Sciences at the University of Maryland. I was involved in a research project in Devine’s lab, which led to the discovery that transposons (jumping genes) can initiate colorectal cancer. 

I am planning to bring cutting-edge clinical trials for patients with gastrointestinal cancers at Saint Luke's. We have an active clinical trials program at Saint Luke's Cancer Institute.  

News

MEDIA COVERAGE: Saint Luke's Announces Center for Precision Oncology
Our precision oncology experts treat your tumor’s mutation, not just your cancer’s location. It’s the only program within 450 miles that offers this level of expertise in clinical oncology, tumor genomics, and computational biology.

Accepted Insurances

  • Aetna Choice POS II
  • Aetna Choice POS II Aexcel Local
  • Aetna Choice POS II Local
  • Aetna Elect Choice
  • Aetna Federal Employees Health Benefit Plan
  • Aetna HMO
  • Aetna HMO Local
  • Aetna Mail Handlers Benefit Plan
  • Aetna Managed Choice
  • Aetna MDOT & Missouri State Highway Patrol
  • Aetna Medicare
  • Aetna Missouri Preferred
  • Aetna MU myChoice Health Program
  • Aetna Open Choice PPO
  • Aetna Select
  • Aetna Select Local
  • Aetna Signature Administrators (ASA)
  • Aetna Workers Comp
  • BCBS of Kansas (call provider)
  • BCBS of Kansas City (PPO)
  • BCBS of Kansas City Freedom Network
  • BCBS of Kansas City Freedom Network Select
  • BCBS of Kansas City Preferred Care
  • BCBS of Kansas City Preferred Care Blue
  • BCBS of Kansas City Traditional
  • Beech Street (PPO)
  • Century Health Solutions (PPO)
  • Cigna (HMO)
  • Cigna (Open Access)
  • Cigna (PPO)
  • Cigna HealthSpring (HMO Medicare Advantage)
  • CompResults (WC)
  • Coventry Advantra Freedom (PPO)
  • Coventry Health and Life Insurance Company
  • Coventry Health Care
  • Coventry Medicare Advantra (PPO)
  • Golden Rule
  • Great West HealthCare (POS)
  • Great West HealthCare (PPO)
  • Great West HealthCare One Health Plan
  • Great West HealthCare One Health Plan/Gen AM
  • Health Choice of Northwest Missouri (PPO)
  • Healthcare USA-MC+ (Aetna Better Health)
  • HealthLink (HMO)
  • HealthLink (PPO) through Freedom Network
  • Home State Health Plan (Missouri practices)
  • Humana (PPOx)
  • Humana Choice Care (PPO)
  • Humana Choice PPO (Medicare Advantage PPO)
  • Humana Gold Choice Medicare Advantage PFFS
  • Humana Gold Plus (HMO)
  • Humana Gold Plus HMO SNP
  • Humana SmartExpress PPO
  • Humana SmartNet PPO
  • Humana SmartSuite PPO
  • HumanaOne
  • Integrated Health Plan
  • Kansas Medicaid
  • Medicare
  • Missouri Care (Missouri practices only)
  • Missouri Medicaid
  • MultiPlan/PCHS (PPO)
  • Occupational Health Management (WC)
  • OHARA Managed Care (WC)
  • ProviDRs Care Network (formerly WPPA)
  • Pyramid Life (Medicare Advantage PPO)
  • Railroad Medicare
  • Sunflower State Health Plan (Kansas practices)
  • TRICARE
  • Triwest Veterans Affairs Patient Centered Community Care
  • United Healthcare Choice
  • United Healthcare Choice Plus
  • United Healthcare Community Plan
  • United Healthcare Definity Health Reimbursement Account
  • United Healthcare Definity Health Savings Account
  • United Healthcare Golden Rule HMO
  • United Healthcare Indemnity
  • United Healthcare Managed Indemnity
  • United Healthcare Options PPO
  • United Healthcare Select
  • United Healthcare Select Plus
  • UnitedHealthcare Evercare DH
  • UnitedHealthcare Evercare DH-POS
  • UnitedHealthcare Evercare DP
  • UnitedHealthcare Evercare RDP
  • UnitedHealthcare Medicare Choice
  • UnitedHealthcare Medicare Choice Essential
  • UnitedHealthcare Medicare Complete
  • UnitedHealthcare Medicare Complete Essential
  • UnitedHealthcare Medicare Complete Plus
  • UnitedHealthcare Medicare DH
  • UnitedHealthcare Medicare Plus Essential
  • US Department of Labor

Publications

Masood A, Shah AR, Koul S, Nisar S, Yaseen J, Ganie A. Exaggerated Thelarche- an uncommon presentation of sexual maturation. Indian Journal of Endocrinology and Metabolism (Endocrine society of India). 2007 Dec; 3&4(1): 39-40.

Masood A, Hudhud K.H, Hegazi A.Z, Gupta NC. BRCA1 mutation presenting with primary breast, ovarian and colon cancer. American Journal of Case Reports. 2008 Jul; 0(9): 338-341

Masood A, Hudhud K.H, Hegazi A.Z, Syed G. Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma. Cases journal. 2008 Aug; 1(1): 116

Hudhud KH, Masood A, Oh Y, Hegazi AZ. Neurocognitive deficits in a patient with small cell lung cancer: a case report. Cases Journal. 2008 Oct; 1(1): 278

Masood A, Kairouz S, Hudhud K.H, Hegazi A, Banu A,Gupta N. Primary non-Hodgkin lymphoma of liver. Current Oncology. 2009 Aug; 16(4): 74-77.

Hudhud KH, Masood A, Hegazi A.Z, Syed G, Banu A, Gupta N. Squamous Cell Carcinoma of Pancreas. American Journal of Case Reports. 2009 Nov; 0(10): 189-192.

Muqbil I, Masood A, Sarkar F.H, Mohammad R.M, Azmi A.S. Progress in Nanotechnology Based Approaches to Enhance the potential of chemopreventive Cancers. 2011 3(1):428-445

Masood A, Azmi AS, Mohammad RM. Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy. Cancers. 2011; 3(2):1527-1549

McDonald P, Lane C, Rojas GE, Masood A. Syndrome of inappropriate anti-diuretic hormone in non-small cell lung carcinoma: a case report. Ecancermedicalscience. 2012;6:279

Liu CY, Chandrasekar PH, Masood A, Schiffer CA. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation. J Oncol Pharm Pract. 2012 May 25.  2013 Mar;19(1):18-23. doi: 10.1177/1078155212447975

Deol A, Abrams J, Masood A, Kadhimi Z, Abidi M, Ayash L, Lum LG, RatanatharathornV, Ubert J. Long Term Follow Up of Patients Proceeding to Transplant Using Plerixafor Mobilized Stem Cells and Incidence of Secondary Acute Myeloid Leukemia / Myelodysplastic Syndrome. Bone Marrow Transplant. 2013 Aug;48(8):1112-6. doi: 10.1038/bmt.2013.10.

Scott E, Gardner E, Masood A, Chuang N, Devine S. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Res 2016 Jun;26(6):745-55

Morgensztern D, Du L, Waqar SN, Patel A, Samson P, Devarakonda S, Gao F, Robinson C, Bradley J, Baggstrom M, Masood A, Govindan R, Puri V. Adjuvant chemotherapy for patients with T2N0M0 non-small-cell lung cancer (NSCLC). J Thorac Oncol 2016 Jun 8

Devarakonda S, Masood A, Govindan R. Next-Generation Sequencing of Lung Cancers: Lessons Learned and Future Directions. Hematol Oncol Clin North Am. 2017 Feb;31(1):1-12.

 

Abstracts:

Devarakonda S, Masood A, Johanns TM, Lanc I, Du L, Ganesh B, Maggi LB., Waqar SN, Morgensztern D, Govindan R. Somatic mutations in mismatch repair pathway genes in non-small cell lung cancer. J Clin Oncol 34, 2016 (suppl; abstr 11523) - Accepted for oral poster discussion

Morgensztern D, Devarakonda S, Masood A, Waqar SN, Carmack AC, Banks KC, Lanman RB, Govindan R. Circulating cell-free tumor DNA (cfDNA) testing in small cell lung cancer.J Clin Oncol 34, 2016 (suppl; abstr e23077)

Mizrahi J, Samson PP, Devarakonda S, Masood A, Govindan R, Gao F, Carpenter D, Robinson CG, Puri V, Morgensztern D, Waqar SN. Clinical characteristics and treatment outcomes of patients with pulmonary salivary gland-like tumors J Clin Oncol 34, 2016 (suppl; abstr 8534)

Waqar SN, Samson PP, Robinson CG, Bradley JD, Devarakonda S, Masood A, Govindan R, Watson M, Gao F, Puri V, Morgensztern D. Prevalence, clinical risk factors and outcomes of patients with lung cancer presenting with brain metastases

Waqar SN, Samson PP, Robinson CG, Bradley JD, Devarakonda S, Masood A, Govindan R, Watson M, Gao F, Puri V, Morgensztern D.Prevalence, clinical risk factors and outcomes of patients with lung cancer presenting with brain metastases. J Clin Oncol 34, 2016 (suppl; abstr 2075)

Du L, Samson P, Waqar SN, Carpenter D, Masood A, Devarakonda S, Robinson C, Govindan R, Puri V, Morgensztern D. Stage III pulmonary large cell neuroendocrine carcinoma (LNEC). J Clin Oncol 34, 2016 (suppl; abstr 8536)

On Staff At

  • Saint Luke's East Hospital
  • Saint Luke's Hospital of Kansas City
  • Saint Luke's North Hospital–Barry Road
  • Saint Luke's North Hospital–Smithville
  • Saint Luke's South Hospital